株式会社タイミー Logo

株式会社タイミー

On-demand staffing platform connecting businesses and workers for flexible spot work.

215A | T

Overview

Corporate Details

ISIN(s):
JP3449040009
LEI:
Country:
Japan
Address:
東京都港区東新橋1丁目5ー2 汐留シティセンター35階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Timee, Inc. operates "Timee," a leading on-demand staffing platform that connects individuals seeking flexible, short-term work with businesses facing immediate labor needs. The service functions as a "spot work" marketplace, allowing users to find and work jobs without the need for traditional applications or interviews, often with the benefit of same-day payment. For businesses, Timee offers a swift solution to labor shortages and fluctuating staffing demands, particularly in sectors like hospitality, logistics, and retail. The company's mission is to create a new infrastructure for work that expands individual potential and helps solve broader societal challenges related to employment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-12 08:30
Interim Report
確認書
Japanese 8.7 KB
2025-06-12 08:30
Interim Report
半期報告書-第9期(2024/11/01-2025/10/31)
Japanese 213.1 KB
2025-01-29 07:31
Post-Annual General Meeting Information
臨時報告書
Japanese 21.1 KB
2025-01-29 07:31
Registration Form
確認書
Japanese 8.7 KB
2025-01-29 07:30
Registration Form
有価証券報告書-第8期(2023/11/01-2024/10/31)
Japanese 2.5 MB
2025-01-29 07:30
Governance Information
内部統制報告書-第8期(2023/11/01-2024/10/31)
Japanese 22.5 KB
2024-07-18 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.9 MB
2024-07-18 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 34.2 KB
2024-07-16 08:00
Registration Form
臨時報告書
Japanese 28.6 KB
2024-07-16 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-07-09 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.9 MB
2024-07-09 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 33.4 KB
2024-07-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-06-21 08:00
Share Issue/Capital Change
臨時報告書
Japanese 29.5 KB
2024-06-21 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.6 MB

Automate Your Workflow. Get a real-time feed of all 株式会社タイミー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社タイミー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社タイミー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR
Resolute Holdings Management, Inc. Logo
Asset management firm acquiring and operationally enhancing companies for long-term growth.
United States of America
RHLD
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan
4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan
9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
ROSS GROUP PLC Logo
A holding company in liquidation, formerly providing supply chain management & technology solutions.
United Kingdom
RGP
ROXX, Inc. Logo
HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.
Japan
241A
SAFTEC CO.,LTD. Logo
Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.
Japan
7464
Salarius Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.
United States of America
SLRX
Saniona Logo
Develops ion channel medicines for rare neurological diseases and epilepsy.
Denmark
SANION

Talk to a Data Expert

Have a question? We'll get back to you promptly.